How Smoking and Lifestyle Choices Affect AMD
Understanding Age-Related Macular Degeneration
Age-related macular degeneration is a disease that damages the macula. The macula is the small central area of the retina responsible for sharp, detailed vision. The retina is the light-sensitive tissue lining the back of the eye. When the macula deteriorates, you may lose the ability to read, drive, or recognize faces, even though your side vision remains intact.
AMD is a complex disease influenced by both genetic and environmental factors. An estimated 18.34 million people aged 40 and older in the United States were living with early-stage AMD in 2019. About 1.49 million had late-stage AMD (PMC, 2022).
AMD has two forms. Dry AMD is the more common type and involves a gradual thinning of the macula. Small yellow deposits called drusen accumulate under the retina. In some people, dry AMD progresses to geographic atrophy, where patches of retinal cells die.
Wet AMD is less common but more severe. It occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood. Vision loss from wet AMD can happen very rapidly without treatment. AMD begins in the dry form and may or may not progress to the wet form over time. These two forms involve different disease processes and require different treatments.
In its early stages, AMD may not cause any noticeable symptoms. The disease can be present in one eye or both. Because early AMD often has no warning signs, many people do not realize they have the condition until significant damage has occurred. Regular eye exams are the most reliable way to catch AMD before it affects your daily life.
Why Smoking Is the Leading Modifiable Risk Factor
A substantial body of research consistently identifies cigarette smoking as the most important modifiable risk factor for AMD. Smokers are twice as likely to develop AMD compared with nonsmokers (CDC, 2023). Current smokers are up to four times more likely to have AMD than people who have not smoked (Macular Society, 2023).
The evidence also shows a dose-response relationship. For people with more than 40 pack-years of smoking, the odds ratio for AMD was 2.75 compared with nonsmokers (Khan et al., BMJ). Smoking can accelerate AMD onset by approximately a decade. Smokers are more likely to develop AMD up to 10 years earlier than nonsmokers (Macular Society, 2023).
Cigarette smoke contains more than 4,500 chemicals, many of which are extremely toxic. These include arsenic, formaldehyde, and ammonia. When inhaled, these chemicals enter the bloodstream and travel to the delicate tissues of the eye, where they damage retinal cell structures.
Smoking increases the activity of free radicals. These are harmful oxygen-derived molecules that accelerate aging and reduce the body's ability to regenerate cells. The retina is especially vulnerable because it has one of the highest metabolic rates of any tissue in the body.
The complement cascade is a part of the immune system that helps fight infection. Recent research has strongly linked overactivation of this cascade to AMD. Cigarette smoke can activate the complement cascade in retinal cells, triggering inflammation and damage.
People with certain genetic variations in their complement genes are especially susceptible to smoke-induced AMD. Research suggests that smokers who have mutations in the HTRA1 gene are 20 times more likely to develop AMD than nonsmokers. It is estimated that as much as one third of all AMD cases result from the combination of genetics and smoking.
Smoking reduces the effectiveness of antioxidants in the body. It may also deplete levels of lutein, a pigment that protects the macula from light damage. People with lower levels of lutein may be more likely to develop AMD.
Cigarette smoke also reduces the amount of oxygen reaching the choroid. The choroid is a network of tiny blood vessels that supplies the retina with nutrients and oxygen. Smoking damages blood vessels throughout the body, from the large arteries of the heart to the tiny capillaries in the eye.
Other Risk Factors and Lifestyle Influences
Age is the strongest overall risk factor for AMD. The odds ratio increases from 1 at ages 55 to 69, to 4.42 to 8.70 at ages 70 to 79, and to 18.8 to 32.3 for ages 80 to 86 (Khan et al., systematic review). Family history of AMD is also significant, with odds ratios ranging from 3.95 to 6.98.
While you cannot change your age or genetic makeup, knowing your family history can help you and a retina specialist plan for earlier screening and monitoring.
A high body mass index (BMI) is associated with an increased risk of AMD. Odds ratios range from 1.06 to 1.35 in large studies. Regular physical activity may help reduce AMD risk by improving cardiovascular health, lowering inflammation, and supporting healthy blood flow to the retina.
Retina specialists and other clinicians often advise patients with AMD to pursue regular physical activity. Walking, swimming, and other moderate exercises can benefit both your general health and your eye health.
Diets rich in antioxidants and unsaturated fatty acids may help slow AMD progression. Key nutrients include lutein, zeaxanthin, vitamins C and E, zinc, and omega-3 fatty acids. Dark leafy greens, colorful fruits and vegetables, nuts, and fatty fish are good dietary sources of these nutrients.
The Age-Related Eye Disease Studies (AREDS and AREDS2) found that specific supplement formulations can reduce the risk of progression from intermediate to advanced AMD (NEI, 2013). Talk with a retina specialist before starting any supplements, as not all formulations are appropriate for every patient.
High blood pressure is a recognized risk factor for AMD, with odds ratios ranging from 1.02 to 1.48 in published studies. The blood vessels in the retina are sensitive to changes in blood pressure. Uncontrolled hypertension can damage these vessels and contribute to AMD progression.
Managing blood pressure through diet, exercise, and medication when prescribed by a doctor is an important step in protecting retinal health.
Research shows an increased risk for AMD in nonsmokers who are exposed to passive smoking. Secondhand smoke contains many of the same toxic chemicals as directly inhaled smoke. Reducing your exposure to secondhand smoke is another meaningful step you can take to lower your AMD risk.
Smoking and AMD Treatment Outcomes
Smoking does not just increase the risk of developing AMD. It also makes treatment less effective. Research by Lee et al. found that smokers had a statistically significant seven-fold higher risk of a poor response to intravitreal therapies (injections of medication into the eye). Even if you already have AMD, the disease is likely to progress faster and respond less well to treatment if you continue to smoke.
Anti-VEGF drugs block vascular endothelial growth factor, a protein that drives abnormal blood vessel growth. These medications are the first-line treatment specifically for wet AMD and are delivered by intravitreal injection. They do not treat dry AMD.
Common anti-VEGF medications used for wet AMD include the following.
- Eylea (aflibercept), typically given every 4 to 8 weeks after an initial loading phase
- Lucentis (ranibizumab), given every 4 weeks
- Vabysmo (faricimab), a bispecific antibody that targets both VEGF and Ang-2, given every 4 to 16 weeks
- Avastin (bevacizumab), which is FDA-approved for cancer and used off-label for eye conditions, given every 4 to 6 weeks
- Eylea HD (high-dose aflibercept), allowing extended dosing intervals of 8 to 16 weeks after loading
Anti-VEGF treatment for wet AMD improves vision in about one out of three people and stabilizes vision in about nine out of ten. The American Academy of Ophthalmology (AAO) updated its guidelines in 2024 and continues to recommend these therapies as first-line treatment for wet AMD (AAO, 2024). However, up to 35 percent of patients do not achieve an optimal response, which is one more reason why prevention and lifestyle modification are so important.
Geographic atrophy is the advanced form of dry AMD. It involves a separate disease process from wet AMD and requires different treatments. Two complement inhibitors are now FDA-approved specifically to slow the progression of geographic atrophy.
Syfovre (pegcetacoplan), a C3 complement inhibitor, is given monthly or every other month. Izervay (avacincaptad pegol), a C5 complement inhibitor, is given monthly. These medications slow the rate of retinal cell loss but do not restore vision that has already been lost. They are not used for wet AMD, and anti-VEGF drugs are not used for geographic atrophy.
For earlier stages of dry AMD, there is no drug treatment that reverses the condition. This is why identifying and acting on modifiable risk factors like smoking is so important.
Concrete Steps to Protect Your Vision
Quitting smoking is the single most impactful lifestyle change you can make to reduce your AMD risk. The benefits begin as soon as you stop. While it may take years for your risk to decline to that of a lifelong nonsmoker, every smoke-free day helps reduce ongoing damage to your retina. Talk with your primary care doctor about smoking cessation programs, nicotine replacement therapy, or prescription medications that can help you quit.
Focus on foods that support retinal health. Practical choices include the following.
- Dark leafy greens such as spinach, kale, and collard greens, which are rich in lutein and zeaxanthin
- Colorful fruits and vegetables including oranges, bell peppers, and berries for vitamins C and E
- Fatty fish such as salmon, mackerel, and sardines for omega-3 fatty acids
- Nuts, seeds, and whole grains for zinc and other micronutrients
Aim for at least 150 minutes per week of moderate-intensity exercise such as brisk walking, cycling, or swimming. Regular activity supports cardiovascular health, which in turn supports healthy blood flow to the retina. Physical activity also helps manage weight and blood pressure, both of which are AMD risk factors.
Work with your doctor to keep blood pressure, cholesterol, and blood sugar within recommended ranges. These conditions affect the blood vessels throughout your body, including those that supply the retina. Previous cataract surgery is also associated with a slightly elevated AMD risk (OR: 1.59), so be sure to inform your retina specialist of your full eye history.
Because early AMD often has no symptoms, regular comprehensive eye exams are essential for early detection. If you are over 50, have a family history of AMD, or have other risk factors, a retina specialist can perform imaging tests to detect changes in the macula before you notice vision loss.
When to See a Retina Specialist
If you have been diagnosed with early or intermediate AMD, regular visits with a retina specialist are important to monitor for progression. Your specialist may use optical coherence tomography (OCT), a noninvasive imaging test, and dilated eye exams to track changes over time.
Certain symptoms require immediate attention. See a retina specialist or go to the emergency room immediately if you experience any of the following.
- A sudden increase in floaters (spots or lines drifting in your vision)
- Flashes of light in one or both eyes
- A curtain or shadow over part of your vision
- Sudden vision loss in one eye
- Straight lines appearing wavy or distorted
If you smoke and have been diagnosed with any stage of AMD, discuss smoking cessation with both your retina specialist and your primary care provider. Quitting can slow disease progression and improve how well your eyes respond to treatment. Do not wait for symptoms to worsen before taking action.
Questions and Answers
The risk of AMD begins to decline after you quit smoking, but it does not drop to the level of a lifelong nonsmoker right away. Studies suggest that former smokers still carry a higher risk than those who have not smoked, though the risk is lower than that of current smokers. The reduction in risk is gradual. Every year without cigarettes allows your body to begin repairing some of the oxidative and vascular damage caused by smoking.
Yes. While no lifestyle change can reverse existing AMD damage, quitting smoking, improving your diet, exercising regularly, and managing blood pressure can all help slow disease progression. For people with intermediate dry AMD, AREDS2 supplement formulations may provide additional benefit (NEI, 2013). Discuss any changes to your diet or supplement routine with a retina specialist before starting.
Research does show an increased risk of AMD in nonsmokers exposed to secondhand smoke. The toxic chemicals in cigarette smoke do not only affect the person smoking. Family members, especially those who live in the same household, may face elevated risk from chronic exposure. Eliminating indoor smoking and reducing exposure to secondhand smoke are practical steps that benefit everyone in the household.
There is not yet enough long-term research to confirm whether e-cigarettes carry the same level of AMD risk as traditional cigarettes. However, e-cigarettes still deliver nicotine and other chemicals that can affect blood vessel health and oxidative stress. Until more data are available, a retina specialist would not consider vaping a safe alternative when it comes to protecting your retinal health.
If you smoke, quitting is the most impactful action you can take. Smoking is the largest modifiable risk factor for AMD, and it worsens outcomes for people who already have the disease. If you do not smoke, maintaining a diet rich in leafy greens and omega-3 fatty acids, staying physically active, and getting regular eye exams are the most effective steps to reduce your risk.